RPL17 and Patent ductus arteriosus: In a metastatic KPC mouse model, anti-PD-1 and anti-Csf1 synergized to reduce collagen deposits and αSMA+ myofibroblasts, both of which improved CD8 T cell infiltration of PDA (118).